Raymond Charles Parrish, II, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serratia marcescens | 4 | 2016 | 46 | 0.840 |
Why?
|
| Pleural Effusion | 1 | 2024 | 341 | 0.740 |
Why?
|
| Self-Fertilization | 4 | 2016 | 5 | 0.740 |
Why?
|
| Caenorhabditis elegans | 5 | 2016 | 1453 | 0.510 |
Why?
|
| Office Visits | 2 | 2016 | 593 | 0.470 |
Why?
|
| Cannabinoids | 1 | 2017 | 172 | 0.470 |
Why?
|
| Hand | 2 | 2016 | 902 | 0.440 |
Why?
|
| Analgesics | 1 | 2017 | 1068 | 0.340 |
Why?
|
| Perception | 1 | 2015 | 1198 | 0.320 |
Why?
|
| Host-Pathogen Interactions | 5 | 2016 | 1448 | 0.320 |
Why?
|
| Biological Evolution | 4 | 2016 | 1075 | 0.290 |
Why?
|
| Ventricular Pressure | 1 | 2024 | 210 | 0.220 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3453 | 0.210 |
Why?
|
| Sputum | 1 | 2024 | 505 | 0.200 |
Why?
|
| Metagenomics | 1 | 2024 | 463 | 0.180 |
Why?
|
| Genetic Variation | 1 | 2016 | 6567 | 0.180 |
Why?
|
| Selection, Genetic | 2 | 2016 | 871 | 0.170 |
Why?
|
| Reproduction | 2 | 2014 | 646 | 0.150 |
Why?
|
| Genetic Fitness | 2 | 2016 | 118 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2017 | 6823 | 0.140 |
Why?
|
| Serratia | 1 | 2016 | 11 | 0.140 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2016 | 29 | 0.140 |
Why?
|
| Inbreeding | 1 | 2016 | 48 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2024 | 1283 | 0.120 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 752 | 0.120 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 3253 | 0.100 |
Why?
|
| Sex | 1 | 2011 | 53 | 0.100 |
Why?
|
| Ventricular Function, Left | 1 | 2024 | 3899 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 1385 | 0.090 |
Why?
|
| Health Literacy | 1 | 2016 | 444 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 20982 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1882 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 1301 | 0.070 |
Why?
|
| Orthopedics | 1 | 2016 | 898 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4909 | 0.070 |
Why?
|
| Freezing | 1 | 2024 | 311 | 0.060 |
Why?
|
| Hermaphroditic Organisms | 2 | 2014 | 7 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2024 | 753 | 0.050 |
Why?
|
| Respiratory System | 1 | 2024 | 562 | 0.050 |
Why?
|
| Logistic Models | 1 | 2015 | 13249 | 0.050 |
Why?
|
| Heart Failure | 1 | 2024 | 11701 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 39957 | 0.040 |
Why?
|
| Hybridization, Genetic | 1 | 2016 | 102 | 0.030 |
Why?
|
| Bacteria | 1 | 2024 | 2190 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 4739 | 0.030 |
Why?
|
| Middle Aged | 3 | 2017 | 220858 | 0.030 |
Why?
|
| Humans | 5 | 2024 | 761222 | 0.030 |
Why?
|
| Animals | 5 | 2016 | 168089 | 0.030 |
Why?
|
| Female | 5 | 2024 | 392552 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 3634 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 442 | 0.020 |
Why?
|
| Extinction, Biological | 1 | 2011 | 30 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 2011 | 147 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 64681 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 870 | 0.020 |
Why?
|
| Male | 4 | 2024 | 360703 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 169292 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 2114 | 0.010 |
Why?
|
| Adult | 2 | 2024 | 221120 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30004 | 0.010 |
Why?
|